GENE ONLINE|News &
Opinion
Blog

RNAi
RNA-Focused Orbital Therapeutics Makes its Industry Debut with Beam Partnership
2022-09-08
Alnylam Posts Positive Phase 2 Results for its RNAi Nephropathy Drug
2022-08-30
FDA Approves Alnylam’s Rare Disease RNAi Therapeutic
2022-06-15
Arrowhead, Vivo Form Visirna to Take on China RNAi Market
2022-04-26
RNAi Player Sirnaomics Squeezes in $50 Million IPO in Hong Kong
2022-01-03
Following Two Years of Promising RNAi Collab, Novo Nordisk Decides to Acquire Dicerna for $3.3 Billion
2021-11-18
Is the Race On for RNAi? A Chinese Pharma’s $450M Deal May Just Be the Start
2021-10-13
Alnylam Nears Fourth Approval with Successful Trial Data for RNAi Drug
2021-01-08
Alnylam Receives FDA Nod for its Third Rare Disease Drug
2020-11-25
Maryland Biopharma Raises $105 Million in Series D to Fund Development of RNAi Therapeutics
2020-10-24
Takeda Collaborates with Arrowhead to Overcome Inherited Disorder via RNAi Therapy
2020-10-10
Alnylam’s RNAi-Based Therapy Lumasiran Impresses in Phase 3 Primary Hyperoxaluria Trials
2020-06-12
COVID-19 Antibody: Vir Biotechnology Partners with Samsung Biologics for Large Scale Manufacturing
2020-04-15
RNA-Silencing Protein AGO4 Functions In Antiviral Defense
2020-02-14
The Rejuvenated Promise of RNA Therapeutics
2020-01-07
1 2
LATEST
Junshi’s PD-1 Antibody Meets Endpoint In Phase 3 Lung Cancer Trial
2023-01-19
Moderna Welcomes Phase 3 Win For RSV Vaccine
2023-01-18
Moving Beyond COVID With mRNA Technology
2023-01-18
Rob Knight and Jing-Yuan Fu Elaborate On Microbiome Research Trends at the 7th Asia Microbiome Conference(AMC)
2023-01-17
CARsgen Taps Huadong to Commercialize Multiple Myeloma CAR-T in China
2023-01-17
Scientists Study Imaging Probes in First-Ever Amputated Human Limb Model
2023-01-16
EMA Plans to Issue Liver Failure Warning for Novartis’ Gene Therapy
2023-01-16
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!